FDA Clearance Tracker · P230001-S008
ColoSense®
Last checked: Nov 20, 2026Latest source record: Jul 3, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jul 3, 2025
Approved
Time to decision
155 days
Received Jan 29, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P230001-S008
- Device name
- ColoSense®
- Applicant
- Geneoscopy, Inc.
- Applicant location
- St. Louis, MO
- Received
- Jan 29, 2025
- Decided
- Jul 3, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P230001
Device type
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
approval for a change in the contract packaging site location for the ColoSense Collection Kit
Source documents
Other decisions for Geneoscopy, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- ColoSense®BreakthroughPMA
P230001 · Decided May 3, 2024 · 469 days after receipt
Device type: System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection (SBB) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.